Killa Acne Extra Strength
Product Images NDC 81746-420

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Killa Acne Extra Strength (NDC 81746-420). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zitsticka, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Drug Facts Panel (Back Of Pack Killa Es)

Drug Facts Panel (Back Of Pack Killa Es)
This is a drug facts label for a product intended to manage acne. The product contains Salicylic Acid 2% and is designed to penetrate pores to eliminate most blemishes. It is for external use only and may cause skin irritation and dryness if used with another topical acne medication. The product should be kept out of reach of children and if swallowed, medical help or Poison Control Center should be contacted immediately. To use, one must cleanse the skin thoroughly before applying the product directly to the affected area. The product should be left on for 2 hours or overnight and then removed. Inactive ingredients include Sodium Hyaluronate, Phytosphingosine HCL, Niacinamide, Oligopeptide-10, Glycolic Acid, Madecassoside, 4-Butylresorcinol, Centella Asiatica Extract. The product has an alpha-hydroxy acid (AHA) that may increase the skin's sensitivity to the sun, and users should use a sunscreen, wear protective clothing, and limit sun exposure while using this product and for a week afterward. Additionally, the product patch material is hydrocolloid.*
FDA Label Image

Zitsticka Killa Extra Strength (Killa Es Pdp)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.